Chouaki, T.
Publications
P305
Medical Mycology, 2025, 63, 12.
Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus.
https://doi.org/10.1093/mmy/myaf110
P286
J. Mycol. Med. 2024, 34, 101490.
Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).
https://doi.org/10.1016/j.mycmed.2024.101490
P255
mBio. 2022, e0092022.
French mycoses study group. Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF network (2012 to 2018).
https://doi.org/10.1128/mbio.00920-22
P226
J. Mycol. Med. 2020, 30, 100970.
Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
doi: 10.1016/j.mycmed.2020.100970
P172
Mycoses 2018, 61, 30-34.
PCR-based detection of A. fumigatus and absence of azole resistance due to TR34/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis.
doi: 10.1111/myc.12702
P163
Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
doi: 10.1093/cid/ciw664
P147
Antimicrob. Agents Chemother. 2016, 60, 5088-5091.
Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
doi: 10.1128/AAC.00630-16
Autres publications scientifiques
PS39
Emerg. Infect. Dis. 2025, 31, 896-905.
Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018.
https://doi.org/10.3201/eid3105.241392
Brevets
Thèse